ELI LILLY (I4V-MC-JAJA)

By June 19, 2019 Active/Enrolling

A Randomized, Active-Controlled, Parallel-Group, Phase 3b/4 Study of Baricitinib in Patients with Rheumatoid Arthritis

Leave a Reply